文献速递免疫规划慢病防控与筛查卫生政策与健康促进

上海社区慢病管理重点人群流感疫苗接种干预真实世界研究

[Real world study of influenza vaccination intervention among key population of chronic disease management in Shanghai community].
PubMed 文献 · Zhonghua Yu Fang Yi Xue Za Zhi · 2020-01-01

该研究纳入上海社区60岁及以上糖尿病、高血压和慢阻肺患者,干预组50 787例接受依托信息系统慢性病门诊的流感疫苗接种宣教与随访,对照组52 268例匹配选取。干预后干预组接种率1.73%高于对照组1.42%(P=0.001),提示干预可提高接种率。

要点

  • 干预后干预组流感疫苗接种率1.73%,高于对照组1.42%(P=0.001)。
  • 完成干预者占56.40%,接受干预者接种可能性更高(OR=1.85,95%CI 1.61~2.11)。
  • 干预前已接种者后续接种可能性极高(OR=260.30,95%CI 215.21~314.83)。

核心结论

  • 实施流感疫苗接种干预可提高上海社区慢性病管理重点人群的流感疫苗接种率。
  • 男性、年龄较低、干预前已接种、接受干预及专业技术人员干预后接种可能性较高。

研究设计与样本

  • 真实世界研究,干预组为上海黄浦、杨浦、宝山、青浦4区社区管理的60岁及以上糖尿病、高血压、COPD患者50 787例。
  • 对照组按地理位置和经济水平匹配选取徐汇、虹口、嘉定、奉贤4区慢性病管理重点人群52 268例。
  • 干预依托信息化慢性病门诊进行流感疫苗接种宣教和随访,实施时间为2017年9月至2018年1月。

主要发现

  • 干预组与对照组年龄分别为(76.76±8.33)和(77.97±8.51)岁(P<0.001)。
  • 干预组完成干预28 644名(56.40%),完成与未完成组年龄构成差异无统计学意义(P=0.095),性别构成差异有统计学意义(P=0.044)。
  • 干预前干预组接种率0.75%(382名)低于对照组1.02%(533名)(χ²=20.96,P<0.001)。
  • 干预后干预组接种率1.73%(496名)高于对照组1.42%(744名)(χ²=11.65,P=0.001)。

关键数值与推荐

  • 男性接种可能性OR(95%CI)为1.29(1.13~1.47)。
  • 年龄较低者OR(95%CI)为0.97(0.96~0.98)。
  • 干预前已接种者OR(95%CI)为260.30(215.21~314.83)。
  • 接受干预者OR(95%CI)为1.85(1.61~2.11)。
  • 专业技术人员OR(95%CI)为1.48(1.10~1.99)。

临床怎么用

  • 可依托慢性病管理信息系统和门诊随访,对60岁及以上慢病重点人群开展流感疫苗接种宣教与随访干预。
  • 干预中可关注男性、较低年龄、既往接种者及专业技术人员等更易接种的人群特征,用于优化动员策略。

局限性

  • 两组年龄、性别、职业构成及干预前接种率存在统计学差异(P<0.001),可能影响组间可比性。
  • 干预后两组接种率均处于较低水平,干预组仅1.73%,效果幅度有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To analyze the effect of influenza vaccination intervention among key populations of chronic disease management in communities of Shanghai. Methods: A total of 50 787 patients aged ≥60 with diabetes, hypertension and chronic obstructive pulmonary disease (COPD) in Huangpu, Yangpu, Baoshan and Qingpu districts of Shanghai from January 2013 to August 2017 were selected as the intervention group, and 52 268 people from key populations with chronic disease management in Xuhui, Hongkou, Jiading and Fengxian districts were selected as the control group according to the geographical location and economic level. The intervention group accepted follow-up and health education of influenza vaccination via chronic disease outpatient based on information system. The implementation time of the intervention was from September 2017 to January 2018. The basic information and diagnosis information of two groups, and intervention completion of the intervention group were obtained from Shanghai chronic disease management information system and hospital record system. Results: The age of the intervention group and the control group were (76.76±8.33) and (77.97±8.51) years old, respectively (P<0.001); and there were statistical differences in gender, occupational and influenza vaccination rate between the two groups (P<0.001). A total of 28 644 (56.40%) subjects of the intervention group received intervention. There was no significant difference in age composition between finished and unfinished intervention groups (P=0.095), and there was significant difference in gender composition (P=0.044). Before the intervention, the vaccination rate of the intervention group was 0.75% (382 subjects) which was lower than that of the control group with 1.02% (533 subjects) (χ(2)=20.96, P<0.001). After the intervention, the vaccination rate of the intervention group was 1.73% (496 subjects) which was higher than that of the control group with 1.42% (744 subjects) (χ(2)=11.65, P=0.001). Subjects that were male, younger, uptake of influenza vaccine before the intervention, received intervention and professional and technical personnel were more likely to take influenza vaccine, with OR (95%CI) 1.29 (1.13-1.47), 0.97 (0.96-0.98), 260.30 (215.21-314.83), 1.85 (1.61-2.11) and 1.48 (1.10-1.99), respectively. Conclusion: Influenza vaccination intervetion raised the vaccination rate of key population of chronic disease management. Male, younger, those who had been vaccinated before the intervention, who received the intervention, and professional and technical personnel were more likely to be vaccinated. 目的: 分析上海市社区慢性病管理重点人群流感疫苗接种干预效果。 方法: 以2013年1月至2017年8月上海黄浦、杨浦、宝山、青浦4个区社区管理的60岁及以上糖尿病、高血压以及慢性阻塞性肺疾病(COPD)患者为干预组,共50 787例;根据地理位置和经济水平匹配选取同期徐汇、虹口、嘉定、奉贤4个区52 268例慢性病管理重点人群作为对照组。采用依托信息化的慢性病门诊对干预组进行流感疫苗接种的宣教和随访,干预实施时间为2017年9月至2018年1月。通过上海市慢性病管理信息系统和临床诊疗信息平台获取干预组和对照组对象的基本情况、诊断信息,以及干预完成情况;从上海市免疫规划信息系统获取2016—2017年流感季(干预前)和2017—2018年流感季(干预后)流感疫苗的相关接种信息。采用多因素logistic回归模型分析慢性病管理重点人群流感疫苗接种的相关因素。 结果: 干预组和对照组年龄分别为(76.76±8.33)和(77.97±8.51)岁(P<0.001);两组间性别构成、职业构成以及干预前流感疫苗接种率差异均有统计学意义(P值均<0.001)。干预组完成干预人数为28 644名(56.40%),完成和未完成组的年龄构成差异无统计学意义(P=0.095),性别构成差异有统计学意义(P=0.044)。干预前干预组的接种率为0.75%(382名),低于对照组(1.02%,533名)(P<0.001),干预后干预组接种率为1.73%(496名),高于对照组(1.42%,744名)(P=0.001)。男性患者、年龄较低者、干预前已接种流感疫苗者、接受干预者和专业技术人员的接种流感疫苗的可能性较高,OR(95%CI)值分别为1.29(1.13~1.47)、0.97(0.96~0.98)、260.30(215.21~314.83)、1.85(1.61~2.11)和1.48(1.10~1.99)。 结论: 实施流感疫苗接种干预可提高慢性病管理重点人群的疫苗接种率,男性、低年龄、干预前接种流感疫苗、接受干预以及专业技术人员干预后接种流感疫苗的可能性高。.

来源:Zhonghua Yu Fang Yi Xue Za Zhi,查看原文。版权归原作者所有。

引用

  1. Wang YH, Ye KY, Wang SY, et al. [Real world study of influenza vaccination intervention among key population of chronic disease management in Shanghai community]. Zhonghua Yu Fang Yi Xue Za Zhi. 2020. PMID: 32268652. doi:10.3760/cma.j.cn112150-20191031-00828

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。